← Open Payments lookup

STEPHEN HENRY: Open Payments

NPI 1811925183 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,550 in 174 payments from 32 companies in 2025. Trend: 2023 $3,681 · 2024 $3,494 · 2025 $3,550

Food & beverage: $3,550
CompanyPaymentsAmount
ABBVIE INC.21$432
Amgen Inc.22$294
Bausch Health US, LLC18$260
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$259
Axsome Therapeutics, Inc.10$258
Otsuka America Pharmaceutical, Inc.11$241
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$214
Gilead Sciences, Inc.9$159
Regeneron Healthcare Solutions, Inc.7$152
GENZYME CORPORATION3$118

Products named: REXULTI, DUPIXENT, APLENZIN, CAPLYTA, VRAYLAR, OTEZLA, Auvelity, XIFAXAN.

Industry payments across CA — which companies pay providers there.